CD4 and urinary bladder carcinoma: In BCG-treated bladder cancer patients, urothelial cells had strong MHC class-2 antigens (HLA-DR) expression, which persisted several months after therapy, suggesting continuous CD4 T cell activation by antigens shared between mycobacterium and cartilage proteoglycan could be responsible for autoimmune arthritis [102].